Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-04-02

FDA Approved: MUCINEX — Supplemental Application (RB Health (US) LLC)

View source ↗

Summary

The FDA approved a supplemental application for Mucinex (guaifenesin) from RB Health (US) LLC to update/expand the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MUCINEX (guaifenesin)

Snippet

SUPPL AP for MUCINEX (GUAIFENESIN)